New drugs for osteoarthritis and infections caused by gram-positive bacteria.
D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006094:Gram-Positive Bacteria; D006801:Humans; D000069349:Linezolid; D000077239:Meloxicam; D010003:Osteoarthritis / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000081:Acetamides; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D023303:Oxazolidinones; D013843:Thiazines; D013844:Thiazoles; D000069349:Linezolid; D000077239:Meloxicam